Zauderer MG - Search Results

1

Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.

Rimner A, Zauderer MG, Gomez DR, Adusumilli PS, Parhar PK, Wu AJ, Woo KM, Shen R, Ginsberg MS, Yorke ED, Rice DC, Tsao AS, Rosenzweig KE, Rusch VW, Krug LM. Rimner A, et al. Among authors: zauderer mg. J Clin Oncol. 2016 Aug 10;34(23):2761-8. doi: 10.1200/JCO.2016.67.2675. Epub 2016 Jun 20. J Clin Oncol. 2016. PMID: 27325859 Free PMC article. Clinical Trial.

2

Leptomeningeal metastases from small cell lung cancer responsive to temozolomide therapy.

Zauderer M, Krug LM, Pietanza MC, O'Rourke D. Zauderer M, et al. J Thorac Oncol. 2010 Oct;5(10):1716-7. doi: 10.1097/JTO.0b013e3181f1cc32. J Thorac Oncol. 2010. PMID: 20871272 Free article. No abstract available.

3

The evolution of multimodality therapy for malignant pleural mesothelioma.

Zauderer MG, Krug LM. Zauderer MG, et al. Curr Treat Options Oncol. 2011 Jun;12(2):163-72. doi: 10.1007/s11864-011-0146-4. Curr Treat Options Oncol. 2011. PMID: 21404104 Free PMC article.

4

Novel therapies in phase II and III trials for malignant pleural mesothelioma.

Zauderer MG, Krug LM. Zauderer MG, et al. J Natl Compr Canc Netw. 2012 Jan;10(1):42-7. doi: 10.6004/jnccn.2012.0007. J Natl Compr Canc Netw. 2012. PMID: 22223868 Free PMC article. Review.

5

Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma.

Rosenzweig KE, Zauderer MG, Laser B, Krug LM, Yorke E, Sima CS, Rimner A, Flores R, Rusch V. Rosenzweig KE, et al. Among authors: zauderer mg. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1278-83. doi: 10.1016/j.ijrobp.2011.09.027. Epub 2012 May 18. Int J Radiat Oncol Biol Phys. 2012. PMID: 22607910 Free PMC article.

6

New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment.

Ladanyi M, Zauderer MG, Krug LM, Ito T, McMillan R, Bott M, Giancotti F. Ladanyi M, et al. Among authors: zauderer mg. Clin Cancer Res. 2012 Sep 1;18(17):4485-90. doi: 10.1158/1078-0432.CCR-11-2375. Epub 2012 Jul 23. Clin Cancer Res. 2012. PMID: 22825583 Free PMC article.

7

Toxicity of initial chemotherapy in older patients with lung cancers.

Zauderer MG, Sima CS, Korc-Grodzicki B, Kris MG, Krug LM. Zauderer MG, et al. J Geriatr Oncol. 2013 Jan;4(1):64-70. doi: 10.1016/j.jgo.2012.09.003. J Geriatr Oncol. 2013. PMID: 23525607 Free PMC article.

8

Pleurectomy/decortication, chemotherapy, and intensity modulated radiation therapy for malignant pleural mesothelioma: rationale for multimodality therapy incorporating lung-sparing surgery.

Zauderer MG, Krug LM. Zauderer MG, et al. Ann Cardiothorac Surg. 2012 Nov;1(4):487-90. doi: 10.3978/j.issn.2225-319X.2012.10.08. Ann Cardiothorac Surg. 2012. PMID: 23977541 Free PMC article. No abstract available.

9

Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations.

Zauderer MG, Bott M, McMillan R, Sima CS, Rusch V, Krug LM, Ladanyi M. Zauderer MG, et al. J Thorac Oncol. 2013 Nov;8(11):1430-3. doi: 10.1097/JTO.0b013e31829e7ef9. J Thorac Oncol. 2013. PMID: 24128712 Free PMC article.

10

Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma.

Zauderer MG, Kass SL, Woo K, Sima CS, Ginsberg MS, Krug LM. Zauderer MG, et al. Lung Cancer. 2014 Jun;84(3):271-4. doi: 10.1016/j.lungcan.2014.03.006. Epub 2014 Mar 14. Lung Cancer. 2014. PMID: 24690410 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters